Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.
about
Treatment of inflammatory myopathy: emerging therapies and therapeutic targetsDevelopments in the classification and treatment of the juvenile idiopathic inflammatory myopathiesNew Insights into Antisynthetase SyndromeInflammatory myopathy and interstitial lung disease in antisynthetase syndrome with PL-7 antibody.Anti-idiotypic monobodies for immune response profiling.Missing links in high quality diagnostics of inflammatory systemic rheumatic diseases: It is all about the patient!Significance of myositis autoantibody in patients with idiopathic interstitial lung diseaseAnti-PM/Scl antibodies are found in Japanese patients with various systemic autoimmune conditions besides myositis and scleroderma.Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II TrialDiagnosis and treatment of inflammatory myopathy: issues and management.An autoimmune myositis-overlap syndrome associated with autoantibodies to nuclear pore complexes: description and long-term follow-up of the anti-Nup syndrome.Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis featuresClinical and pathological roles of Ro/SSA autoantibody system.Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositisModern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics.Acute Onset Anti-Synthetase Syndrome With Pericardial Effusion and Non-Specific Interstitial Pneumonia.Single-specificity anti-Ku antibodies in an international cohort of 2140 systemic sclerosis subjects: clinical associations.Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression.Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype.Clinical heterogeneity and prognostic features of South Australian patients with anti-synthetase autoantibodies.Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.Acute digital ischemia: A rare presentation of antisynthetase syndrome.Correlation of clinicoserologic and pathologic classifications of inflammatory myopathies: study of 178 cases and guidelines for diagnosis.Cutting edge issues in polymyositis.Interstitial Lung Disease in Idiopathic Inflammatory Myopathy.Cutaneous lupus erythematosus: clinical aspects and molecular pathogenesis.Autoantibodies in polymyositis and dermatomyositis.Clinical heterogeneity and outcomes of antisynthetase syndrome.Antisynthetase syndrome: An under-recognized cause of interstitial lung disease.A three-way interplay of DR4, autoantibodies and synovitis in biopsy-proven idiopathic inflammatory myositis.Anti-SS-A/Ro antibody positivity as a risk factor for relapse in patients with polymyositis/dermatomyositis.Clinical and serological associations of autoantibodies to the Ku70/Ku80 heterodimer determined by a novel chemiluminescent immunoassay.Altered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles.Ro52/TRIM21-deficient expression and function in different subsets of peripheral blood mononuclear cells is associated with a proinflammatory cytokine response in patients with idiopathic inflammatory myopathies.Anti-Jo-1 myositis and the antiphospholipid syndrome showing right ventricular thrombus: a novel overlap syndrome with atypical presentation.High frequencies and co-existing of myositis-specific autoantibodies in patients with idiopathic inflammatory myopathies overlapped to rheumatoid arthritis.Prolidase deficiency breaks tolerance to lupus-associated antigens.Systemic sclerosis: demographic, clinical and serological features in 100 Iranian patients.Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study.
P2860
Q26796546-05B555BD-4325-470E-86C6-0A018BE52E5BQ26863125-F7E8EFAF-47F6-4AB0-A2B1-B8518AA977E9Q33572873-FACDD7B9-C062-4EB8-A62A-1F081CD59928Q34296861-7E43398F-AEAF-45C2-8057-E414F8B6AB8AQ34347058-292B9651-04DC-4053-A499-D9F60770FDECQ35309739-156DBF49-965A-493B-86C3-E95B70E19A99Q35421571-28ED7BD2-6C8B-4C50-8351-43B3AAAC01B3Q35532333-2B194036-AD31-4CF7-A633-F52D33AF3F13Q35833312-2D20C7C5-4A2B-47B1-A0FF-5E037B2F2E41Q36059517-EE53C767-7C11-4215-942B-9975076257DCQ36150817-98E1EA05-BABB-4775-B292-3E6F6631AE53Q36150826-8B76C577-8532-46CA-9658-83C54FCF1E70Q36469094-591C6D3A-907A-40ED-AC42-A3A59C9662AEQ37023594-D922BAB8-6352-400D-BD81-C4ED7E1EDA12Q37095730-3E99AF59-FB47-4191-A02F-BDFD7F33B94CQ37154302-121399A6-62A0-4329-B7C9-8DA9A9B7A1C7Q37226360-36F868AB-A267-421A-9782-C4690E569CD8Q37368405-488DB817-7456-4AE6-A304-8683D0315D54Q37480302-1F04C661-1F91-4B30-9118-C9A8610D8497Q37613347-0E269BD0-1EE3-4D9A-8860-C407A98B5F84Q37670981-8B6F8630-F100-4073-98A1-D85B2E12E8E1Q37674765-81209B4D-465E-4767-A975-A2B3524D228BQ37679306-0AF39547-A60F-4EFE-B6B4-973C681B32D7Q37726608-F31F4D6D-1A6B-412F-AF44-7794161584F4Q37824617-E6E9CDF0-03BA-4CB1-A49A-4D5A8C1866BDQ37937430-EEE76F59-9469-4D5C-8F02-64043333891EQ38086856-91BA6D7A-890A-4EC5-A5CA-FFFEDD4D5EE9Q38099556-C3B903E8-7EE6-400F-8B45-3CA00EDC0FC8Q38116464-51EF3621-AC62-4DAC-B12B-29E16EC0B8C4Q38341312-5DE58AAF-C921-416D-AB91-85EFF6D288F3Q38413380-E03C37E4-53BA-4825-9344-698CCD388B1EQ38809464-470E2D7E-174E-4D82-A342-ACF3CAE3674AQ38851103-EE741638-7405-43CA-B5BE-F2DFA118123EQ38960509-2EF4A391-2E1C-4BE0-AF9A-BAF70EDA9912Q39114608-152F5A39-E693-4CE3-AEAC-775CF2525E98Q39572709-15B651C0-C945-4FBF-995F-AF7A17D769C3Q39762134-7D5A8E2F-BC4B-4613-A13A-AC4E2469C655Q39863980-0D83865E-7536-42BC-B054-346431E2A1E5Q40087587-B83F74B9-51DB-4540-A472-0A281608C555Q40130278-A27F86AA-8E04-49A0-9A67-9028FA8B005B
P2860
Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Heterogeneity of autoantibodie ...... linical features and outcomes.
@ast
Heterogeneity of autoantibodie ...... linical features and outcomes.
@en
Heterogeneity of autoantibodie ...... linical features and outcomes.
@nl
type
label
Heterogeneity of autoantibodie ...... linical features and outcomes.
@ast
Heterogeneity of autoantibodie ...... linical features and outcomes.
@en
Heterogeneity of autoantibodie ...... linical features and outcomes.
@nl
prefLabel
Heterogeneity of autoantibodie ...... linical features and outcomes.
@ast
Heterogeneity of autoantibodie ...... linical features and outcomes.
@en
Heterogeneity of autoantibodie ...... linical features and outcomes.
@nl
P2093
P2860
P356
P1476
Heterogeneity of autoantibodie ...... linical features and outcomes.
@en
P2093
Ira N Targoff
Jean-Luc Senécal
Martial Koenig
Yves Troyanov
P2860
P2888
P356
10.1186/AR2276
P577
2007-01-01T00:00:00Z
P5875
P6179
1043190712